![]() |
市場調查報告書
商品編碼
1933319
全球機器人輔助手術人工智慧(AI)市場:市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的分析以及未來預測(2026-2034)AI in Robot-Assisted Surgery Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
由於技術進步、基於人工智慧的手術解決方案的日益普及以及對精準微創手術需求的不斷增長,全球機器人輔助手術人工智慧(AI)市場正在快速擴張。預計該市場將從2025年的73.2億美元成長到2026年的104.6億美元,到2034年將達到2047.1億美元,預測期內複合年增長率高達45.03%。
人工智慧技術正被整合到機器人手術系統中,以幫助外科醫生更精準、高效、安全地完成複雜的手術。 應用程式包括分析 CT 和 MRI 掃描以建立患者專屬的 3D 模型、切口規劃、植入物位置優化以及即時手術路徑引導。人工智慧還能穩定機械手臂、糾正手部震顫並自動執行縫合等重複性任務,進而幫助減輕外科醫師的疲勞並改善患者的治療效果。
主要市場領導者包括 Intuitive Surgical, Inc.、Medtronic, Inc.、Zimmer Biomet Holdings, Inc. 和 Globus Medical, Inc.。這些公司透過廣泛的產品組合、創新產品的推出以及策略性的地理擴張來維持其市場主導地位。
市場動態
市場驅動因素
該市場的主要驅動力是人工智慧技術的進步,它為機器人手術帶來了適應性、精確性和效率。人工智慧系統可以從海量的手術資料集中學習,動態應對意外併發症,並為外科醫生提供即時決策支援。
例如,2025年7月,約翰霍普金斯大學的研究人員報告稱,一台經過實際手術視訊訓練的手術機器人能夠自主完成膽囊切除術的關鍵步驟,展現出更高的適應性和手術精度。
市場限制因子
高昂的資本和營運成本仍然是重要的限制因素。先進機器人系統(例如達文西手術系統)的購買成本在50萬美元到250萬美元之間,而年度服務費和每次手術所需的器械成本進一步限制了其普及,尤其是在新興經濟體。
市場機會
對人工智慧整合機器人手術的投資不斷增加,為創新創造了機會。例如,2025年6月,ForSight Robotics公司籌集了1.25億美元,用於開發其用於眼科手術的ORYOM平台,旨在提高手術精度、改善患者預後並提升外科醫生效率。此類投資正在推動市場擴張和技術進步。
市場挑戰
醫療器材和手術機器人的嚴格監管環境帶來了許多挑戰。品質系統合規、設備報告和安全驗證需要投入大量資源,這可能會延遲產品批准。 2024年8月,美國FDA向Globus Medical發出警告,指出其未能滿足設備通報要求,凸顯了企業面臨的監管障礙。
市場趨勢
一個關鍵趨勢是將基於雲端的外科培訓和機器學習模型相結合,從而實現外科教育和績效評估的標準化。基於人工智慧的模型提供個人化回饋並推薦最佳實踐,有助於提升醫療機構的技能水準。 2023年2月,Ascensus Surgical與Google雲端合作,利用集中式資料分析增強其 "績效導向手術" 框架,進而改善訓練效果。 此外,人工智慧正越來越多地被用於自動化縫合和組織分割等精細操作,同時仍能確保外科醫生完全掌控手術過程。
依產品/服務分類:
依專科分類:
依最終使用者劃分:
The global AI in robot-assisted surgery market is witnessing rapid expansion due to technological advancements, increasing adoption of AI-based surgical solutions, and rising demand for precise and minimally invasive procedures. The market was valued at USD 7.32 billion in 2025, projected to grow to USD 10.46 billion in 2026, and is expected to reach USD 204.71 billion by 2034, registering a remarkable CAGR of 45.03% over the forecast period.
AI technologies are being integrated into robotic surgical systems to assist surgeons in performing complex procedures with enhanced precision, efficiency, and safety. Applications include analyzing CT and MRI scans to create patient-specific 3D models, planning incision sites, optimizing implant positioning, and guiding surgical pathways in real time. AI also stabilizes robotic arms, cancels hand tremors, and automates repetitive tasks such as suturing, reducing surgeon fatigue and improving outcomes.
Major players leading the market include Intuitive Surgical, Inc., Medtronic plc, Zimmer Biomet Holdings, Inc., and Globus Medical, Inc., with broad product portfolios, innovative launches, and strategic geographic expansion supporting their dominance.
Market Dynamics
Market Drivers
The market is primarily driven by advancing AI capabilities, offering adaptability, precision, and efficiency in robotic surgeries. AI-enabled systems can learn from vast surgical datasets, adjust dynamically to unexpected complications, and provide real-time decision support to surgeons.
For instance, in July 2025, researchers at Johns Hopkins University reported that a surgical robot trained on real procedure videos performed a critical phase of gallbladder removal autonomously, demonstrating enhanced adaptability and surgical precision.
Market Restraints
High capital and operating costs remain significant restraints. Acquisition costs for advanced robotic systems, such as the da Vinci, range from USD 0.5 million to USD 2.5 million, with annual service fees and procedure-specific instrument costs further limiting adoption, especially in emerging economies.
Market Opportunities
Growing investment in AI-integrated robotic surgeries offers opportunities for innovation. For example, in June 2025, ForSight Robotics secured USD 125 million to develop the ORYOM platform for eye surgeries, enhancing precision, patient outcomes, and surgeon efficiency. Such investments drive market expansion and technological evolution.
Market Challenges
The stringent regulatory landscape for medical devices and surgical robotics poses challenges. Compliance with quality systems, device reporting, and safety validation requires substantial resources and can delay product approvals. In August 2024, the U.S. FDA issued a warning to Globus Medical for failing to meet device reporting requirements, highlighting the regulatory hurdles faced by companies.
Market Trends
A key trend is the integration of cloud-based surgical training and machine learning models, which standardizes surgical education and performance assessment. AI-based models provide personalized feedback, highlight best practices, and improve skill development across institutions. In February 2023, Asensus Surgical, Inc. collaborated with Google Cloud to enhance its Performance-Guided Surgery framework, utilizing centralized data analytics for improved training outcomes. Additionally, AI is increasingly used to automate micro-tasks like suturing and tissue segmentation, while surgeons retain full control.
By Product & Services:
By Specialty:
By End-User:
Competitive Landscape
The market is semi-concentrated, with key players such as Intuitive Surgical, Medtronic, Zimmer Biomet, Stryker, Smith & Nephew, Globus Medical, Siemens Healthineers, Asensus Surgical, CMR Surgical, and Virtuoso Surgical. These companies focus on innovation, strategic partnerships, and geographic expansion.
Key Developments:
Conclusion
The global AI in robot-assisted surgery market is projected to grow from USD 7.32 billion in 2025 to USD 204.71 billion by 2034, at a CAGR of 45.03%. Growth is driven by increasing adoption of AI for precise, efficient, and safe surgeries, investments in innovation, and integration of cloud-based training systems. Despite high costs and stringent regulatory challenges, AI-enabled robotic surgeries are poised to transform surgical care, improve patient outcomes, and set new standards for minimally invasive procedures globally.
Segmentation By Product & Services
By Specialty
By End User
By Geography